Trending Now
- Shivraj Singh Chouhan has launched Mission 29 (29 LS seats) for 2024 Lok Sabha polls.
- ‘BJP can only win in Gau mutra states’: DMK MP Senthil Kumar makes a controversial remark in Lok Sabha
- 15 Trains Cancelled As City Continues to Reel Under Waterlogging; Death Toll Reaches 20
Businesswire
Taro Annual Report on Form 20-F Available
June 25, 2018
Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2018, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com.
Hard copies of the report may be ordered free of charge by sending requests to:
Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne, NY 10532
attention: William J. Coote or
via email to William.Coote@Taro.com
Additionally, the report may be accessed on the SEC’s website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005431/en/
Source: Businesswire
